| |
|
|
|
Immunogen Inc
|
|
6.57 0 (+0.00%) |
8/23/2017 4:00pm |
|
Open: |
6.57 |
Pre close: |
6.57 |
Target:
|
8.49
|
|
High: |
6.73 |
Low: |
6.44 |
Resistance:
|
7.27
8.49
|
|
Volume: |
1,621,111 |
Market Cap: |
588.65M |
Support:
|
5.97
5.17
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.30
 |
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
5.97 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
5.21 |
Stochastic Oscillator |
%K(14,3):
|
91.88 |
|
MA(250): |
3.59 |
%D(3): |
74.86 |
|
Average Volume(K) |
3-Month: |
262674
|
52-Week |
High:
|
8.04 |
|
10-Days: |
34026 |
Low: |
1.51 |
|
RSI |
RSI(14):
|
58.30 |
Change(%): |
126.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
89.60 |
|
EPS Est. Current Year |
-0.840 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
82.11 |
|
EPS Est. Next Year |
-1.510 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.36 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
426.7 |
% Held by Institutions |
91.70 |
|
Forward EPS |
-1.489 |
Gross Profit (p.s.) |
0.670 |
Shares Short (K) |
17450 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.775 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
-127.24 |
Operating Cash Flow
(M) |
-117.21 |
P/S |
613200000.00 |
|
Operating Margin |
-90.63 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
-5.02 |
|
|
|
|
|
|
|
